Key Highlights: Implications: Sanofi’s Hyderabad bet signals all-in pharma offshoring, vacuuming up AI/data talent that smaller players can’t touch while crushi...
Key Highlights: Implications: Imfinzi storms endometrial cancer protocols, giving oncologists a potent immunotherapy combo that leapfrogs chemo-only standards. AstraZeneca doubles do...
Key Highlights: Implications: IIL grabs first-mover advantage in niche viral vaccine space, dominating government tenders and regional immunization drives. Homegrown breakthrough smashes i...
Key Highlights: Implications: Sun ignites generics price war against Novo/Eli Lilly premium brands, slashing obesity therapy costs and exploding Tier-2/3 access. Dual T2D/weight...
Key Highlights: Implications: Tishtha detonates pricing bombs on Roche’s Tecentriq and MSD’s Opdivo, handing cash-strapped hospitals a lifeline while exploding p...
Key Highlights: Implications: Jubilant catapults into top-tier CRO/CDMO contender, snatching complex molecule work from Lonza/Capricor as India chemistry talent goes global. Noid...
Key Highlights: Implications: The appointment underlines ChemWerth’s intent to treat India not just as a sourcing base but as a strategic growth market for its re...
Key Highlights: Implications: Lantern’s Bengaluru expansion accelerates U.S. biotech offshoring of AI-drug discovery to India, intensifying talent competition with Dr. Reddy’s and Biocon w...
Relevant Industry Developments India’s biopharmaceutical sector is no longer defined solely by its global dominance in generics. Over the past decade, biologics and biosimilars have emerged as o...
Latest Developments in Pharma Talent and Innovation India’s pharmaceutical industry has long been recognized for its manufacturing capabilities, particularly in the generics sector. However, in ...
